SEC Filing Summary: Form 13F Information Table
Business Context and Reporting Period
Company: Alphabet Inc.
Filing Type: Form 13F Information Table
Reporting Period: The filing text lists a period of "2025 Dec 31" in the metadata, but the document content itself does not explicitly state the specific quarter or year end date within the table rows. Form 13F filings are typically submitted quarterly.
Subject: This filing discloses equity securities held by Alphabet Inc. (or its reporting managers) as of the period end. It is not a financial performance report for Alphabet Inc. itself, but rather a disclosure of its investment portfolio.
Key Financial Metrics and Portfolio Composition
The filing details a portfolio of equity holdings. Key metrics include the number of shares held and the aggregate market value of each position. The filing does not provide Alphabet Inc.'s own revenue, profit, cash flow, or debt metrics.
| Issuer | Shares Held | Value (USD) | Voting Authority |
|---|---|---|---|
| Planet Labs PBC | 31,942,641 | $629,908,881 | Sole |
| Spacex (Ast) Spacemobile Inc | 8,943,486 | $649,565,388 | Sole |
| Arm Holdings PLC | 1,960,784 | $214,333,299 | Sole |
| Revolution Medicines Inc | 3,345,102 | $266,437,374 | Sole |
| UiPath Inc | 7,034,337 | $115,292,783 | Sole |
| GitLab Inc | 2,724,712 | $102,258,441 | Sole |
| Tempus AI Inc | 1,551,102 | $91,592,573 | Sole |
| Prime Medicine Inc | 16,562,498 | $57,471,868 | Sole |
Note: Values are aggregated where multiple entries for the same issuer appeared in the source text (e.g., Revolution Medicines, Freshworks). The filing lists 33 distinct line items across various issuers.
Material Changes and Observations
The provided text is a static snapshot of holdings and does not contain comparative data against a prior period. Therefore, material changes in position size or value cannot be calculated from this document alone. The portfolio is heavily concentrated in technology, biotechnology, and healthcare sectors.
Guidance, Risks, and Contingencies
Management Commentary: None provided in this filing type.
Risks: The filing includes a standard SEC disclaimer stating that the Commission has not reviewed the information for accuracy or completeness. Investors should not assume the data is accurate or complete.
Unusual Items: The filing lists significant positions in pre-IPO or recently public companies (e.g., Spacemobile, Tempus AI, Arm Holdings), indicating a venture capital or strategic investment strategy rather than passive index tracking.
Investor Verification Checklist
- Reporting Date Accuracy: Verify the actual quarter end date, as the metadata "2025 Dec 31" appears to be a future date relative to current real-time, suggesting a potential data entry error in the source metadata or a hypothetical scenario.
- Valuation Method: Confirm if the "Value" column represents fair market value at period end or cost basis (Form 13F requires fair market value).
- Aggregation: Verify if multiple entries for the same issuer (e.g., Freshworks, Revolution Medicines) represent different classes of stock or different accounts managed by Alphabet.
- Voting Rights: Note that all listed positions show "Sole" or "Shared" voting authority, indicating active management of these stakes.